Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS‐CoV‐2: A Combined in silico and in vitro Study-Reference-Cited by-同舟云学术

Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS‐CoV‐2: A Combined in silico and in vitro Study

Published:2021-09-16 Issue:2 Volume:41 Page:2100062
ISSN:1868-1743
Container-title:Molecular Informatics
language:en
Short-container-title:Molecular Informatics

Author:

Durdagi Serdar¹²³⁴^ORCID,Orhan Muge Didem⁵^ORCID,Aksoydan Busecan¹²^ORCID,Calis Seyma⁵^ORCID,Dogan Berna¹^ORCID,Sahin Kader¹^ORCID,Shahraki Aida¹⁶^ORCID,Iyison Necla Birgül⁶^ORCID,Avsar Timucin⁵⁷^ORCID

Affiliation:

1. Computational Biology and Molecular Simulations Laboratory Department of Biophysics School of Medicine Bahcesehir University 34734 Istanbul Turkey

2. Neuroscience Program Graduate School of Health Sciences Bahçeşehir University 34353 Istanbul Turkey

3. Virtual Drug Screening and Development Laboratory School of Medicine Bahcesehir University 34734 Istanbul Turkey

4. Head of Department of Basic Medical Sciences Head of Department of Biophysics School of Medicine Bahcesehir University Durdagi Research Group (DRG) 34734 Istanbul Turkey

5. Department of Medical Biology School of Medicine Bahcesehir University 34734 Istanbul Turkey

6. Department of Molecular Biology and Genetics Bogazici University 34470 Istanbul Turkey

7. Head of Department of Medical Biology

Publisher

Wiley

Subject

Organic Chemistry,Computer Science Applications,Drug Discovery,Molecular Medicine,Structural Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/minf.202100062

Reference50 articles.

1. Emerging coronaviruses: Genome structure, replication, and pathogenesis

2. Coronavirus Infections—More Than Just the Common Cold